Evidence map›Paper›PMID 27114534›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Divergent non-heme iron enzymes in the nogalamycin biosynthetic pathway.

Vilja Siitonen, Brinda Selvaraj, Laila Niiranen, Ylva Lindqvist, Gunter Schneider, Mikko Metsä-Ketelä

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Dioxygen activation by nonheme iron enzymes with the 2-His-1-carboxylate facial triad that generate high-valent oxoiron oxidants.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Vilja SiitonenDepartment of Biochemistry, University of Turku, FIN-20014, Turku, Finland;
Brinda SelvarajDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77, Stockholm, Sweden.
Laila NiiranenDepartment of Biochemistry, University of Turku, FIN-20014, Turku, Finland;
Ylva LindqvistDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77, Stockholm, Sweden.
Gunter SchneiderDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77, Stockholm, Sweden mikko.mk@gmail.com gunter.schneider@ki.se.
Mikko Metsä-KeteläDepartment of Biochemistry, University of Turku, FIN-20014, Turku, Finland; mikko.mk@gmail.com gunter.schneider@ki.se.
Karolinska Institutet · SEUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nogalamycin, an aromatic polyketide displaying high cytotoxicity, has a unique structure, with one of the carbohydrate units covalently attached to the aglycone via an additional carbon-carbon bond. The underlying chemistry, which implies a particularly challenging reaction requiring activation of an aliphatic carbon atom, has remained enigmatic. Here, we show that the unusual C5''-C2 carbocyclization is catalyzed by the non-heme iron α-ketoglutarate (α-KG)-dependent SnoK in the biosynthesis of the anthracycline nogalamycin. The data are consistent with a mechanistic proposal whereby the Fe(IV) = O center abstracts the H5'' atom from the amino sugar of the substrate, with subsequent attack of the aromatic C2 carbon on the radical center. We further show that, in the same metabolic pathway, the homologous SnoN (38% sequence identity) catalyzes an epimerization step at the adjacent C4'' carbon, most likely via a radical mechanism involving the Fe(IV) = O center. SnoK and SnoN have surprisingly similar active site architectures considering the markedly different chemistries catalyzed by the enzymes. Structural studies reveal that the differences are achieved by minor changes in the alignment of the substrates in front of the reactive ferryl-oxo species. Our findings significantly expand the repertoire of reactions reported for this important protein family and provide an illustrative example of enzyme evolution.

Indexed as

Amino Acid SequenceBacterial ProteinsBase SequenceBiosynthetic PathwaysEvolution, MolecularGenetic VariationHemeIronKetoglutaric AcidsModels, GeneticMultienzyme ComplexesNogalamycinOxygenasesStreptomycesBacterial ProteinsHemeIronKetoglutaric AcidsMultienzyme ComplexesNogalamycinOxygenasescrystal structureiron-dependent oxygenasenatural product biosynthesisStreptomycesα-ketoglutarate–dependent oxygenase

Identifiers

PMID27114534
PMCPMC4868444
OpenAlexW2342651497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.